T Cells Going Innate

Trends in Immunology

Volumn 37, Issue 8, 2016, Pages 546-556

  Seyda, Midas ^a,b   Elkhal, Abdallah ^a   Quante, Markus ^a   Falk, Christine S ^b,c   Tullius, Stefan G ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c Center for Experimental and Clinical Infection Research   (Germany)

Author keywords

adaptive immunity; innate immunity; NK cell receptors; T cells; transplantation

Indexed keywords

CD28 ANTIGEN; CYTOKINE; NATURAL KILLER CELL RECEPTOR; T LYMPHOCYTE RECEPTOR; ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR;

ADAPTIVE IMMUNITY; AGING; ALLOIMMUNITY; CHRONIC INFLAMMATION; CROSS REACTION; HUMAN; IMMUNOCOMPETENCE; IMMUNOSUPPRESSIVE TREATMENT; INNATE IMMUNITY; MOLECULAR RECOGNITION; NONHUMAN; PROTEIN FUNCTION; REVIEW; T LYMPHOCYTE; ANIMAL; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; INFLAMMATION; LYMPHOCYTE ACTIVATION; METABOLISM; NATURAL KILLER CELL; SIGNAL TRANSDUCTION; T LYMPHOCYTE SUBPOPULATION;

ADAPTIVE IMMUNITY; AGING; ANIMALS; ANTIGENS; ANTIGENS, CD28; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY, INNATE; IMMUNOSUPPRESSION; INFLAMMATION; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, NATURAL KILLER CELL; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS;

EID: 84991745789     PISSN: 14714906     EISSN: 14714981     Source Type: Journal    
DOI: 10.1016/j.it.2016.06.004     Document Type: Review

References (94)

1. 1 Ljunggren, H.G., Kärre, K., In search of the ‘missing self’: MHC molecules and NK cell recognition. Immunol. Today 11 (1990), 237–244.
2. 2 Bauer, S., et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285 (1999), 727–729.
3. 3 Chen, L., Flies, D.B., Molecular mechanisms of T cell co-stimulation and co-inhibition. Nat. Rev. Immunol. 13 (2013), 227–242.
4. 4 Janeway, C.A., Approaching the asymptote?. Evolution and revolution in Immunology. Cold Spring Harb. Symp. Quant. Biol. 54 (1989), 1–13.
5. 5 O'Leary, J.G., et al. T cell- and B cell-independent adaptive immunity mediated by natural killer cells. Nat. Immunol. 7 (2006), 507–516.
6. 6 Vivier, E., et al. Innate or adaptive immunity? The example of natural killer cells. Science 331 (2011), 44–49.
7. 7 Wencker, M., et al. Innate-like T cells straddle innate and adaptive immunity by altering antigen-receptor responsiveness. Nat. Immunol. 15 (2014), 80–87.
8. 8 Bedoui, S., et al. Parallels and differences between innate and adaptive lymphocytes. Nat. Immunol. 17 (2016), 490–494.
9. 9 Kastenmüller, W., et al. A spatially-organized multicellular innate immune response in lymph nodes limits systemic pathogen spread. Cell 150 (2012), 1235–1248.
10. 10 Jabri, B., et al. TCR specificity dictates CD94/NKG2A expression by human CTL. Immunity 17 (2002), 487–499.
11. 11 Strid, J., et al. Acute upregulation of an NKG2D ligand promotes rapid reorganization of a local immune compartment with pleiotropic effects on carcinogenesis. Nat. Immunol. 9 (2008), 146–154.
12. + T and innate NK lymphocytes independent of cognate antigen during microbial pathogen invasion. Immunity 37 (2012), 549–562.
13. 13 Chu, T., et al. Bystander-activated memory CD8 T cells control early pathogen load in an innate-like, NKG2D-dependent manner. Cell Rep. 3 (2013), 701–708.
14. + T cells escape TGF-β control and contribute to early microbial pathogen response. Nat. Commun., 5, 2014, 5150.
15. 15 McQueen, B., et al. NKG2D and CD28 receptors differentially activate mTOR to alter murine effector CD8+ T cell differentiation. Immunology 147 (2016), 305–320.
16. + T cell memory recall but not effector responses. Nat. Med. 18 (2012), 422–428.
17. + T cells in vitro. Blood 102 (2003), 2541–2546.
18. 18 Richer, M.J., et al. Inflammatory IL-15 is required for optimal memory T cell responses. J. Clin. Invest. 125 (2015), 3477–3490.
19. 19 Marçais, A., et al. The metabolic checkpoint kinase mTOR is essential for IL-15 signaling during the development and activation of NK cells. Nat. Immunol. 15 (2014), 749–757.
20. 20 Vallejo, A.N., et al. Modulation of CD28 expression: distinct regulatory pathways during activation and replicative senescence. J. Immunol. 162 (1999), 6572–6579.
21. + T cells exhibit increased antigen threshold requirements for recall proliferation. J. Exp. Med. 211 (2014), 345–356.
22. + T cells rapidly acquire NK1.1 and NK cell-associated molecules upon stimulation in vitro and in vivo. J. Immunol. 165 (2000), 3673–3679.
23. + T cells. J. Immunol. 169 (2002), 1444–1452.
24. 24 Tarazona, R., et al. Increased expression of NK cell markers on T lymphocytes in aging and chronic activation of the immune system reflects the accumulation of effector/senescent T cells. Mech. Ageing Dev. 121 (2000), 77–88.
25. 25 Peralbo, E., et al. Invariant NKT and NKT-like lymphocytes: two different T cell subsets that are differentially affected by ageing. Exp. Gerontol. 42 (2007), 703–708.
26. + T cells. J. Immunol. 180 (2008), 4550–4560.
27. 27 Suessmuth, Y., et al. CMV reactivation drives posttransplant T-cell reconstitution and results in defects in the underlying TCRβ repertoire. Blood 125 (2015), 3835–3850.
28. 28 Hassouneh, F., et al. Effect of age and latent CMV infection on CD8+ CD56+ T cells (NKT-like) frequency and functionality. Mech. Ageing Dev., 2016, 10.1016/j.mad.2015.12.003 Published online January 2, 2016.
29. 29 Strauss-Albee, D.M., et al. Coordinated regulation of NK receptor expression in the maturing human immune system. J. Immunol. 193 (2014), 4871–4879.
30. 30 Espinosa, J., et al. CD57+ CD4 T cells underlie belatacept-resistant allograft rejection. Am. J. Transplant. 16 (2016), 1102–1112.
31. + T cells in a subset of clinically stable kidney transplant recipients: a potential marker for late graft dysfunction. J. Am. Soc. Nephrol. 25 (2014), 1856–1868.
32. + immunosenescence predicts post-transplant cutaneous squamous cell carcinoma in high-risk patients. J. Am. Soc. Nephrol. 27 (2016), 1505–1515.
33. 33 Li, X.C., et al. Memory T cells in transplantation – progress and challenges. Curr. Opin. Organ Transplant. 18 (2013), 387–392.
34. 34 Chalasani, G., et al. Recall and propagation of allospecific memory T cells independent of secondary lymphoid organs. Proc. Natl. Acad. Sci. U.S.A. 99 (2002), 6175–6180.
35. 35 Hidalgo, L.G., et al. NK cell transcripts and NK cells in kidney biopsies from patients with donor-specific antibodies: evidence for NK cell involvement in antibody-mediated rejection. Am. J. Transplant. 10 (2010), 1812–1822.
36. 36 Hirohashi, T., et al. A novel pathway of chronic allograft rejection mediated by NK cells and alloantibody. Am. J. Transplant. 12 (2012), 313–321.
37. 37 Venner, J.M., et al. The molecular landscape of antibody-mediated kidney transplant rejection: evidence for NK involvement through CD16a Fc receptors. Am. J. Transplant. 15 (2015), 1336–1348.
38. 38 Zhang, Z-X., et al. Natural killer cells mediate long-term kidney allograft injury. Transplantation 99 (2015), 916–924.
39. 39 Zhang, Z-X., et al. Natural killer cells play a critical role in cardiac allograft vasculopathy in an interleukin-6–dependent manner. Transplantation 98 (2014), 1029–1039.
40. 40 Li, L., et al. A common peripheral blood gene set for diagnosis of operational tolerance in pediatric and adult liver transplantation. Am. J. Transplant. 12 (2012), 1218–1228.
41. 41 Beilke, J.N., et al. NK cells promote islet allograft tolerance via a perforin-dependent mechanism. Nat. Med. 11 (2005), 1059–1065.
42. 42 Yu, G., et al. NK cells promote transplant tolerance by killing donor antigen-presenting cells. J. Exp. Med. 203 (2006), 1851–1858.
43. 43 van der Touw, W., et al. NK cells are required for costimulatory blockade induced tolerance to vascularized allografts. Transplantation 94 (2012), 575–584.
44. + T cells in a T-bet-dependent manner. Transplantation 99 (2015), 391–399.
45. 45 Allard, M., et al. HLA-E-restricted cross-recognition of allogeneic endothelial cells by CMV-Associated CD8 T cells: a potential risk factor following transplantation. PLoS ONE, 7, 2012, e50951.
46. 46 Romagnani, C., et al. Identification of HLA-E-specific alloreactive T lymphocytes: a cell subset that undergoes preferential expansion in mixed lymphocyte culture and displays a broad cytolytic activity against allogeneic cells. Proc. Natl. Acad. Sci. U.S.A. 99 (2002), 11328–11333.
47. null cells in NKG2D-dependent glomerular endothelial injury and kidney allograft dysfunction. Am. J. Transplant. 16 (2016), 1113–1128.
48. −/− mice. Nat. Med. 7 (2001), 557–562.
49. 49 Kim, J., et al. The activating immunoreceptor NKG2D and its ligands are involved in allograft transplant rejection. J. Immunol. 179 (2007), 6416–6420.
50. 50 Venner, J.M., et al. Molecular landscape of T cell-mediated rejection in human kidney transplants: prominence of CTLA4 and PD ligands. Am. J. Transplant. 14 (2014), 2565–2576.
51. 51 Chen, G., et al. T cell aging: a review of the transcriptional changes determined from genome-wide analysis. Front. Immunol., 4, 2013, 121.
52. 52 Mou, D., et al. CD28 negative T cells: is their loss our gain?. Am. J. Transplant. 14 (2014), 2460–2466.
53. + T-cell activation mediated by cytokines. Proc. Natl. Acad. Sci. U.S.A. 109 (2012), 9971–9976.
54. 54 Suarez-Ramirez, J.E., et al. CD8 T cells in innate immune responses: using STAT4-dependent but antigen-independent pathways to gamma interferon during viral infection. MBio 5 (2014), e01978–e2014.
55. 55 Holzapfel, K.L., et al. Antigen-dependent versus -independent activation of invariant NKT cells during infection. J. Immunol. 192 (2014), 5490–5498.
56. 56 Wang, X., et al. Human invariant natural killer T cells acquire transient innate responsiveness via histone H4 acetylation induced by weak TCR stimulation. J. Exp. Med. 209 (2012), 987–1000.
57. 57 Vahl, J.C., et al. NKT cell-TCR expression activates conventional T cells in vivo, but is largely dispensable for mature NKT cell biology. PLoS Biol., 11, 2013, e1001589.
58. 58 Boyman, O., et al. Homeostatic maintenance of T cells and natural killer cells. Cell. Mol. Life Sci. 69 (2012), 1597–1608.
59. 59 Lafferty, K.J., Cunningham, A.J., A new analysis of allogeneic interactions. Aust. J. Exp. Biol. Med. Sci. 53 (1975), 27–42.
60. short correlates with resistance toward CD95-mediated apoptosis by blocking death-inducing signaling complex activity. J. Immunol. 165 (2000), 6293–6300.
61. 61 McNerney, M.E., et al. Role of natural killer cell subsets in cardiac allograft rejection. Am. J. Transplant. 6 (2006), 505–513.
62. 62 Szot, G.L., et al. Different mechanisms of cardiac allograft rejection in wildtype and CD28-deficient mice. Am. J. Transplant. 1 (2001), 38–46.
63. 63 Zhang, Z-X., et al. NK cells induce apoptosis in tubular epithelial cells and contribute to renal ischemia-reperfusion injury. J. Immunol. 181 (2008), 7489–7498.
64. 64 Markiewicz, M.A., et al. RAE1ɛ ligand expressed on pancreatic islets recruits NKG2D receptor-expressing cytotoxic T cells independent of T cell receptor recognition. Immunity 36 (2012), 132–141.
65. 65 D'Addio, F., et al. CD160Ig fusion protein targets a novel costimulatory pathway and prolongs allograft survival. PLoS ONE, 8, 2013, e60391.
66. 66 Agrawal, S., et al. Cutting edge: MHC class I triggering by a novel cell surface ligand costimulates proliferation of activated human T cells. J. Immunol. 162 (1999), 1223–1226.
67. + T cells through interaction with herpesvirus entry mediator. Nat. Immunol. 9 (2008), 176–185.
68. 68 Tu, T.C., et al. CD160 is essential for NK-mediated IFN-γ production. J. Exp. Med. 212 (2015), 415–429.
69. 69 Vincenti, F., et al. A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study). Am. J. Transplant. 10 (2010), 535–546.
70. + T cell responses. J. Exp. Med. 211 (2014), 297–311.
71. 71 Nakajima, H., et al. Activating interactions in human NK cell recognition: the role of 2B4-CD48. Eur. J. Immunol. 29 (1999), 1676–1683.
72. + effector T cells. J. Immunol. 167 (2001), 6165–6170.
73. + T cells with a potent CD160-mediated cytolytic effector function. Eur. J. Immunol. 36 (2006), 2359–2366.
74. null T cells. J. Immunol. 168 (2002), 3839–3846.
75. − T cells in patients with rheumatoid arthritis. Eur. J. Immunol. 40 (2010), 378–387.
76. 76 Nakajima, T., et al. T-cell-mediated lysis of endothelial cells in acute coronary syndromes. Circulation 105 (2002), 570–575.
77. − T cell proinflammatory and effector responses in patients with coronary artery disease. J. Immunol. 181 (2008), 5233–5241.
78. + T cells specific for human cytomegalovirus. Eur. J. Immunol. 36 (2006), 3198–3206.
79. − T cells in multiple sclerosis. J. Immunol. 194 (2015), 2099–2109.
80. 80 Casado, J.G., et al. CD8 T cells expressing NK associated receptors are increased in melanoma patients and display an effector phenotype. Cancer Immunol. Immunother. 54 (2005), 1162–1171.
81. + large granular lymphocytes triggered by a tumor-expressed activating ligand. Leukemia 16 (2002), 855–860.
82. 82 Roberts, A.I., et al. NKG2D receptors induced by IL-15 costimulate CD28-negative effector CTL in the tissue microenvironment. J. Immunol. 167 (2001), 5527–5530.
83. 83 Meresse, B., et al. Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity 21 (2004), 357–366.
84. 84 von Geldern, M., et al. TCR-independent cytokine stimulation induces non-MHC-restricted T cell activity and is negatively regulated by HLA class I. Eur. J. Immunol. 36 (2006), 2347–2358.
85. 85 Kuylenstierna, C., et al. NKG2D performs two functions in invariant NKT cells: direct TCR-independent activation of NK-like cytolysis and co-stimulation of activation by CD1d. Eur. J. Immunol. 41 (2011), 1913–1923.
86. + T lymphocytes during active, latent, and resolved infection and its relation with CD57. J. Immunol. 174 (2005), 6088–6094.
87. + T cells. Blood 113 (2009), 6619–6628.
88. 88 Li, X.C., et al. Costimulatory pathways in transplantation: challenges and new developments. Immunol. Rev. 229 (2009), 271–293.
89. 89 Xu, H., et al. The allo- and viral-specific immunosuppressive effect of belatacept, but not tacrolimus, attenuates with progressive T cell maturation. Am. J. Transplant. 14 (2014), 319–332.
90. − memory CD8 T cell proliferation and CTLA4-Ig resistant memory CD8 T cell activation. Am. J. Transplant. 14 (2014), 1277–1289.
91. 91 Mou, D., et al. Viral-induced CD28 loss evokes costimulation independent alloimmunity. J. Surg. Res. 196 (2015), 241–246.
92. 92 Williams, M.A., et al. Characterization of Virus-Mediated Inhibition of Mixed Chimerism and Allospecific Tolerance. J. Immunol. 167 (2001), 4987–4995.
93. 93 Hoffmann, U., et al. NK cells of kidney transplant recipients display an activated phenotype that is influenced by immunosuppression and pathological staging. PLoS ONE, 10, 2015, e0132484.
94. null memory T cells, which is resistant to tacrolimus and everolimus. Transplantation 97 (2014), 47–55.